This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Medarex Inc.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: To Uyen Thi Do: Innovator in Monoclonal Antibodies
Introduction
To Uyen Thi Do is a prominent inventor based in Sacramento, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work focuses on innovative solutions for treating B cell malignancies.
Latest Patents
To Uyen Thi Do holds a patent for "CD19 antibodies and their uses." This patent provides isolated monoclonal antibodies, specifically human monoclonal antibodies that bind to CD19 with high affinity. The patent also includes nucleic acid molecules encoding these antibodies, expression vectors, and host cells for their expression. Additionally, it covers immunoconjugates, bispecific molecules, and pharmaceutical compositions that incorporate the CD19 antibodies. Methods for detecting CD19 and treating various B cell malignancies, including non-Hodgkin's lymphoma, are also disclosed in her patent.
Career Highlights
To Uyen Thi Do is associated with Medarex Inc., where she continues to advance her research and development efforts. Her work has been instrumental in the field of immunotherapy, contributing to the understanding and treatment of cancer.
Collaborations
Some of her notable coworkers include Chetana Rao-Naik and David J King, who collaborate with her on various projects within the company.
Conclusion
To Uyen Thi Do's innovative work in monoclonal antibodies represents a significant advancement in cancer treatment. Her contributions continue to impact the field of biotechnology positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile